Risks of cardiac arrhythmia and mortality among patients using new-generation macrolides, fluoroquinolones, and β-lactam/β-lactamase inhibitors: a Taiwanese nationwide study - Chou, H W; Wang, J L; Chang, C H (Clin Infect Dis, 2015)
et al.